T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$7.49B |
| 2 |
Micron Technology
MU
|
+$6.62B |
| 3 |
Lam Research
LRCX
|
+$3.45B |
| 4 |
Applied Materials
AMAT
|
+$3.03B |
| 5 |
Advanced Micro Devices
AMD
|
+$2.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$12.1B |
| 2 |
Apple
AAPL
|
+$11.6B |
| 3 |
Amazon
AMZN
|
+$3.54B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.07B |
| 5 |
Keysight
KEYS
|
+$1.82B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.73% |
| 2 | Healthcare | 11.3% |
| 3 | Financials | 10.32% |
| 4 | Communication Services | 9.66% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Hanover Insurance
THG
$7.57B
| $392M | 0.04% |
1,831,579
+447,437
| +32% | +$84.7M |
|
327
Nu Holdings
NU
$65.6B
| $392M | 0.04% |
29,338,410
-14,379,789
| -33% | -$194M |
|
328
Moderna
MRNA
$79.4B
| $391M | 0.04% |
5,589,560
+4,850,982
| +657% | +$251M |
|
329
Steris
STE
$20.4B
| $386M | 0.04% |
1,834,238
+71,103
| +4% | +$15.2M |
|
330
TD Synnex
SNX
$20.8B
| $386M | 0.04% |
1,442,470
+1,166,765
| +423% | +$281M |
|
331
Flex
FLEX
$42.4B
| $383M | 0.04% |
2,365,800
+1,193,887
| +102% | +$145M |
|
332
United Parcel Service
UPS
$79.9B
| $382M | 0.04% |
3,551,678
-168,925
| -5% | -$17.6M |
|
333
CBRE Group
CBRE
$39B
| $381M | 0.04% |
2,825,981
-92,894
| -3% | -$12.8M |
|
334
Cloudflare
NET
$124B
| $379M | 0.04% |
1,544,713
+149,845
| +11% | +$32.8M |
|
335
Viper Energy
VNOM
$7.96B
| $379M | 0.04% |
8,935,623
-176,449
| -2% | -$8.15M |
|
336
Lazard
LAZ
$3.58B
| $376M | 0.04% |
8,962,415
-639,484
| -7% | -$29.3M |
|
337
Carpenter Technology
CRS
$19.7B
| $375M | 0.04% |
608,722
+104,719
| +21% | +$49.3M |
|
338
Vornado Realty Trust
VNO
$6.48B
| $375M | 0.04% |
9,546,372
+301,904
| +3% | +$9.76M |
|
339
Royal Caribbean
RCL
$64.9B
| $375M | 0.04% |
1,180,563
-231,070
| -16% | -$64.6M |
|
340
Twist Bioscience
TWST
$12.1B
| $374M | 0.04% |
3,634,652
+3,564,347
| +5,070% | +$232M |
|
341
Scholar Rock
SRRK
$5.92B
| $374M | 0.04% |
6,794,837
+588,219
| +9% | +$28.4M |
|
342
MACOM Technology Solutions
MTSI
$21.8B
| $373M | 0.04% |
980,134
+65,284
| +7% | +$21.7M |
|
343
StoneX
SNEX
$8.06B
| $370M | 0.04% |
4,677,243
-530,754
| -10% | -$39.8M |
|
344
Aramark
ARMK
$14.5B
| $368M | 0.04% |
6,469,715
+762,040
| +13% | +$37.6M |
|
345
Weatherford International
WFRD
$6.08B
| $365M | 0.04% |
4,472,757
+489,101
| +12% | +$49.6M |
|
346
FirstEnergy
FE
$25.1B
| $364M | 0.04% |
7,652,081
+142,150
| +2% | +$6.75M |
|
347
Insmed
INSM
$25.7B
| $363M | 0.04% |
3,405,290
+312,483
| +10% | +$37.8M |
|
348
GSK
GSK
$98.7B
| $363M | 0.04% |
6,923,642
-399,191
| -5% | -$21.1M |
|
349
Diamondback Energy
FANG
$52.3B
| $362M | 0.04% |
2,060,266
-705,496
| -26% | -$137M |
|
350
Novanta
NOVT
$5.44B
| $361M | 0.04% |
2,222,445
+438,021
| +25% | +$63.3M |
|
Similar funds
T. Rowe Price Associates's Q2 2026 Portfolio in Review
As of Q2 2026, T. Rowe Price Associates held 3,356 positions worth $999B, up 16% from $865B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q2 2026 filing shows 224 new, 2,237 increased, 645 reduced and 116 closed positions. Its largest new stake was SpaceX: 10,709,016 shares worth $1.83B. The largest sale was Microsoft, an estimated $12.1B.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2026 buy was SpaceX: 10,709,016 shares worth $1.83B.
- T. Rowe Price Associates added most to Alphabet (Google) Class A in Q2 2026, an estimated $7.49B increase.
- T. Rowe Price Associates's biggest Q2 2026 reduction was Microsoft, cutting an estimated $12.1B.
- T. Rowe Price Associates fully exited Sibanye-Stillwater in Q2 2026, selling an estimated $40.4M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $999B portfolio in Q2 2026.
- T. Rowe Price Associates opened 224 new positions and closed 116 in Q2 2026.
- T. Rowe Price Associates's portfolio value rose 16% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.